SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may compromise vaccine effectiveness and the ability of antibodies triggered by previous infection to protect against re-infection (1). Here we investigated whether Omicron escapes antibody neutralization in South Af...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel G. Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem A. Hanekom, Anne von Gottberg, Jinal N. Bhiman, Richard Lessells, Mahomed‐Yunus S. Moosa, Miles P. Davenport, Túlio de Oliveira, Penny L. Moore, Alex Sigal
Materiálatiipa: Pré-impressão
Giella:eaŋgalasgiella
Almmustuhtton: 2021
Liŋkkat:https://doi.org/10.1101/2021.12.08.21267417
https://www.medrxiv.org/content/medrxiv/early/2021/12/17/2021.12.08.21267417.full.pdf
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

https://doi.org/10.1101/2021.12.08.21267417
https://www.medrxiv.org/content/medrxiv/early/2021/12/17/2021.12.08.21267417.full.pdf

Geahča maid